Alpha Centric Advisors LLC Portfolio Holdings

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Alpha Centric Advisors LLC has filed its 13F form on October 30, 2024 for Q3 2024 where it was disclosed a total value porftolio of $118 Million distributed in 231 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Harmony Biosciences Holdings, Inc. with a value of $3.88M, Galapagos Nv with a value of $3.12M, New Residential Investment Corp. with a value of $2.76M, Merck & Co., Inc. with a value of $2.73M, and Ellington Financial Inc. with a value of $2.6M.

Examining the 13F form we can see an decrease of $2.93M in the current position value, from $121M to 118M.

Alpha Centric Advisors LLC is based out at San Juan, PR

Below you can find more details about Alpha Centric Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $118 Million
Healthcare: $67.3 Million
Real Estate: $16 Million
ETFs: $14.1 Million
Financial Services: $9.24 Million
Industrials: $4.72 Million
Technology: $3.59 Million
Consumer Cyclical: $1.64 Million
Energy: $564,000
Other: $1.21 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$34.6B
$31,000 0.03% of portfolio
59
Q3 2024 Reduced 1.67%
$10.4B
$36,000 0.03% of portfolio
210
Q3 2024 Reduced 2.33%
$41.8B
$30,000 0.03% of portfolio
267
Q3 2024 Reduced 2.55%
$29.7B
$25,000 0.02% of portfolio
148
Q3 2024 Reduced 2.63%
$76.8B
$27,000 0.02% of portfolio
99
Q3 2024 Reduced 1.98%
$54.8B
$18,000 0.02% of portfolio
164
Q3 2024 Reduced 2.96%
$8.95B
$26,000 0.02% of portfolio
339
Q3 2024 Reduced 2.87%
$1.55B
$20,000 0.02% of portfolio
49
Q3 2024 Reduced 3.92%
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Chimera Invt Corp
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.01%
Microbot Med Inc
-
$0 0.0% of portfolio
-
Q2 2020 New
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.44%
New York Mtg Tr Inc
-
$0 0.0% of portfolio
-
Q3 2023 Added 8.07%
Vyne Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 13.53%
Onity Group Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 9.32%
Indivior PLC
-
$0 0.0% of portfolio
-
Q3 2024 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Safehold Inc
-
$0 0.0% of portfolio
-
Q2 2023 Reduced 0.01%
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 82.56%
-
$0 0.0% of portfolio
-
Q3 2024 Added 9.68%
Gsk PLC
-
$0 0.0% of portfolio
-
Q4 2023 Reduced 30.0%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 5.45%
Star Hldgs
-
$0 0.0% of portfolio
-
Q1 2023 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 92.67%
Two Harbors Inventment Corpo
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 62.4%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Pennymac Corp
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 50.89%
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q3 2024 New
Intuitive Machines Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 231
  • Current Value $118 Million
  • Prior Value $121 Million
  • Filing
  • Period Q3 2024
  • Filing Date October 30, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 28 stocks
  • Additional Purchases 32 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 137 stocks
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email